0001181431-12-057476.txt : 20121107 0001181431-12-057476.hdr.sgml : 20121107 20121107191711 ACCESSION NUMBER: 0001181431-12-057476 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121105 FILED AS OF DATE: 20121107 DATE AS OF CHANGE: 20121107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mahatme Sandesh CENTRAL INDEX KEY: 0001511034 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 121188116 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3450 MONTE VILLA PARKWAY STREET 2: SUITE 101 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 425-354-5038 MAIL ADDRESS: STREET 1: 3450 MONTE VILLA PARKWAY STREET 2: SUITE 101 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 rrd359839.xml FORM 4 X0306 4 2012-11-05 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001511034 Mahatme Sandesh C/O SAREPTA THERAPEUTICS, INC. 3450 MONTE VILLA PARKWAY, SUITE 101 BOTHELL WA 98021 0 1 0 0 Senior Vice President, CFO Stock Option (right to buy) 23.85 2012-11-05 4 A 0 150000 0.00 D 2022-11-05 Common Stock 150000 150000 D Stock Appreciation Right 23.85 2012-11-05 4 A 0 100000 0.00 D 2022-11-05 Common Stock 100000 100000 D 25% of the shares subject to the option vest on the first anniversary measured from November 5, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. 25% of the shares subject to the stock appreciation right (the "SAR") vest on the first anniversary measured from November 5, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the SAR will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. /s/ Sandesh Mahatme 2012-11-07